Bradley Canino

Stock Analyst at Stifel

(0)
# 4704
Out of 5,358 analysts
102
Total ratings
23.21%
Success rate
-16.89%
Average return
Main Sectors:
Top Industries:
22 Stocks
Name Action PT Current % Upside Ratings Updated
BDTX Black Diamond Therap...
Maintains: Buy
16 15
2.58 481.4% 5 Mar 7, 2025
ALXO ALX Oncology Holding...
Maintains: Hold
3 2
0.58 158.62% 8 Mar 7, 2025
RLAY Relay Therapeutics
Maintains: Buy
27 23
3.35 586.57% 5 Feb 27, 2025
ARVN Arvinas
Maintains: Buy
63 51
7.53 577.29% 6 Feb 12, 2025
JANX Janux Therapeutics
Maintains: Strong Buy
70 115
26.18 339.27% 2 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
5 4
0.18 2122.22% 5 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
40 41
11.45 258.08% 5 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
26 19
6.72 182.74% 6 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
39 42
13.04 222.09% 4 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 40
20.61 94.08% 4 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
115 135
78.06 72.94% 4 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
9.33 114.36% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.35 640.74% 1 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
1.52 557.89% 17 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
90 99
56.23 76.06% 7 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
1.72 713.95% 4 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
9.09 340.04% 1 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
120 130
127.82 1.71% 5 Apr 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
35 55
47.64 15.45% 4 Feb 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 23
n/a n/a 5 Feb 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
n/a n/a 1 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 45
n/a n/a 2 Mar 1, 2022